Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

No more vaccine exports until you fulfill your contracts, EU tells AstraZeneca

Thu, 25th Mar 2021 21:56

March 25 (Reuters) - AstraZeneca cannot export any
more COVID-19 vaccines from Europe until is makes good on its
contracts with the European Union, EU Commission chief Ursula
von der Leyen said after a meeting of the leaders of the
27-nation bloc.

"We have to and want to explain to our European citizens
that they get their fair share," she told a news conference late
on Thursday, adding that companies had to honour their contracts
with the EU before exporting to other regions. "And this is of
course the case with AstraZeneca," von der Leyen said.

"I think it is clear for the company that, first of all the
company has to catch up, has to honour the contract it has with
the European member states, before it can engage again in
exporting vaccines."
(Reporting by Sabine Siebold)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.